163 related articles for article (PubMed ID: 29691855)
1. Virus-neutralising antibody responses in horses following vaccination with Equivac® HeV: a field study.
Tan R; Hodge A; Klein R; Edwards N; Huang JA; Middleton D; Watts SP
Aust Vet J; 2018 May; 96(5):161-166. PubMed ID: 29691855
[TBL] [Abstract][Full Text] [Related]
2. Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area.
Fehér O; Bakonyi T; Barna M; Nagy A; Takács M; Szenci O; Joó K; Sárdi S; Korbacska-Kutasi O
Vet Immunol Immunopathol; 2020 Sep; 227():110087. PubMed ID: 32629300
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the effect of Equivac® HeV Hendra virus vaccination on Thoroughbred racing performance.
Schemann K; Annand EJ; Reid PA; Lenz MF; Thomson PC; Dhand NK
Aust Vet J; 2018 Apr; 96(4):132-141. PubMed ID: 29399777
[TBL] [Abstract][Full Text] [Related]
4. The Hendra virus vaccine: perceptions regarding the role of antibody titre testing.
Barrett RS; Wiethoelter A; Halpin K
Aust Vet J; 2021 Sep; 99(9):412-418. PubMed ID: 34151419
[TBL] [Abstract][Full Text] [Related]
5. Is there a benefit from an early booster vaccination in the control of equine influenza?
Heldens JG; van Loon AA; van de Zande S
Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
[TBL] [Abstract][Full Text] [Related]
6. Rhabdovirus-based vaccine platforms against henipaviruses.
Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
[TBL] [Abstract][Full Text] [Related]
7. Sero-Monitoring of Horses Demonstrates the Equivac
Halpin K; Graham K; Durr PA
Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358146
[TBL] [Abstract][Full Text] [Related]
8. Response of Australian veterinarians to the announcement of a Hendra virus vaccine becoming available.
Mendez D; Büttner P; Speare R
Aust Vet J; 2013 Aug; 91(8):328-31. PubMed ID: 23889099
[TBL] [Abstract][Full Text] [Related]
9. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
Gildea S; Arkins S; Walsh C; Cullinane A
Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
[TBL] [Abstract][Full Text] [Related]
10. Hendra vaccine success announced.
Balzer M
Aust Vet J; 2011 Jul; 89(7):N2-3. PubMed ID: 21834199
[No Abstract] [Full Text] [Related]
11. Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health.
Middleton D; Pallister J; Klein R; Feng YR; Haining J; Arkinstall R; Frazer L; Huang JA; Edwards N; Wareing M; Elhay M; Hashmi Z; Bingham J; Yamada M; Johnson D; White J; Foord A; Heine HG; Marsh GA; Broder CC; Wang LF
Emerg Infect Dis; 2014 Mar; 20(3):372-9. PubMed ID: 24572697
[TBL] [Abstract][Full Text] [Related]
12. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
[TBL] [Abstract][Full Text] [Related]
13. Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection.
Wernery U; Rodriguez M; Raghavan R; Syriac G; Miriam Thomas M S; Elizabeth SK; Federico Ronchi G; Muhammed R; Patteril NA; Joseph S
Equine Vet J; 2021 Jul; 53(4):826-833. PubMed ID: 33011979
[TBL] [Abstract][Full Text] [Related]
14. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
[TBL] [Abstract][Full Text] [Related]
15. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study.
Gildea S; Arkins S; Walsh C; Cullinane A
Vaccine; 2011 May; 29(22):3917-22. PubMed ID: 21419776
[TBL] [Abstract][Full Text] [Related]
16. Playing with fire - What is influencing horse owners' decisions to not vaccinate their horses against deadly Hendra virus infection?
Goyen KA; Wright JD; Cunneen A; Henning J
PLoS One; 2017; 12(6):e0180062. PubMed ID: 28636633
[TBL] [Abstract][Full Text] [Related]
17. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
[TBL] [Abstract][Full Text] [Related]
18. Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals.
Fougerolle S; Legrand L; Garrett D; Birand I; Foursin M; D'Ablon X; Bayssat P; Newton RJ; Pronost S; Paillot R
Vaccine; 2016 Jul; 34(33):3787-95. PubMed ID: 27269055
[TBL] [Abstract][Full Text] [Related]
19. Hendra Virus: An Update on Diagnosis, Vaccination, and Biosecurity Protocols for Horses.
Wang X; Wise JC; Stewart AJ
Vet Clin North Am Equine Pract; 2023 Apr; 39(1):89-98. PubMed ID: 36737284
[TBL] [Abstract][Full Text] [Related]
20. The impact of different equine influenza vaccine products and other factors on equine influenza antibody levels in Thoroughbred racehorses.
Ryan M; Gildea S; Walsh C; Cullinane A
Equine Vet J; 2015 Nov; 47(6):662-6. PubMed ID: 25238593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
